A detailed history of Yousif Capital Management, LLC transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Yousif Capital Management, LLC holds 6,483 shares of ANIP stock, worth $365,381. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,483
Previous 6,252 3.69%
Holding current value
$365,381
Previous $398,000 3.02%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$54.33 - $65.72 $12,550 - $15,181
231 Added 3.69%
6,483 $386,000
Q2 2024

Jul 31, 2024

SELL
$58.53 - $68.82 $37,459 - $44,044
-640 Reduced 9.29%
6,252 $398,000
Q1 2024

Apr 26, 2024

SELL
$54.2 - $69.69 $91,164 - $117,218
-1,682 Reduced 19.62%
6,892 $476,000
Q4 2023

Feb 01, 2024

BUY
$48.72 - $65.43 $32,544 - $43,707
668 Added 8.45%
8,574 $472,000
Q3 2023

Oct 30, 2023

BUY
$50.28 - $64.61 $27,151 - $34,889
540 Added 7.33%
7,906 $459,000
Q2 2023

Aug 02, 2023

BUY
$37.29 - $53.83 $16,333 - $23,577
438 Added 6.32%
7,366 $396,000
Q1 2023

May 02, 2023

SELL
$37.61 - $45.72 $34,225 - $41,605
-910 Reduced 11.61%
6,928 $275,000
Q4 2022

Jan 09, 2023

SELL
$31.9 - $41.95 $65,395 - $85,997
-2,050 Reduced 20.73%
7,838 $0
Q3 2022

Nov 04, 2022

SELL
$29.83 - $38.01 $23,506 - $29,951
-788 Reduced 7.38%
9,888 $318,000
Q2 2022

Aug 01, 2022

SELL
$23.09 - $33.46 $26,322 - $38,144
-1,140 Reduced 9.65%
10,676 $317,000
Q1 2022

May 12, 2022

BUY
$26.91 - $47.15 $71,446 - $125,183
2,655 Added 28.98%
11,816 $332,000
Q4 2021

Jan 31, 2022

BUY
$32.97 - $56.85 $302,038 - $520,802
9,161 New
9,161 $422,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $982M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Yousif Capital Management, LLC Portfolio

Follow Yousif Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yousif Capital Management, LLC with notifications on news.